Protagonist Therapeutics Inc (PTGX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 3.64B
P/E Ratio
80.26
Revenue (TTM)
$ 209.18M
Volume
0
52W High
$ 61.89
52W Low
$ 33.31
Dividend Yield
0.00%
Beta
2.22
Technicals
50-Day MA
55.8614
200-Day MA
47.3467
52 Week High
61.89
52 Week Low
33.31
About PTGX
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
Employees
130
Headquarters
Newark, CA
CEO
Dr. Dinesh V. Patel Ph.D.